A rare cutaneous lymphoma that can mimic lupus and melt away on steroids still belongs in the malignancy category, based on how it behaves off treatment.
Michael Girardi, MD
Advertisement
Articles by Michael Girardi, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Sacituzumab Govitecan Monotherapy and In Combination With Pembrolizumab in Frontline TNBC
2
Dr Tolaney on the FDA Approval of First-Line Sacituzumab Govitecan Plus Pembrolizumab for TNBC
3
Daratumumab Retreatment Displays Activity in Relapsed Myeloma Following Continuous Frontline Therapy
4
Dr Morgans on the Design of the ARACOG Trial in Prostate Cancer
5